Buradasınız

Anasayfa » Content

THERAPEUTIC APPLICATIONS OF CITICOLINE AND METHYLCOBALAMINE COMBINATION

Journal Name:

  • Advance Research in Pharmaceuticals and Biologicals

Publication Year:

  • 2012

Key Words:

Author Name
Abstract (2. Language): 
Combination of citicoline and methylcobalamine is available in market as variable dose combination. It has been approved by DCGI in the year 2010. This combination is generally prescribed for the management of metabolic disordered nerve rejuvenation and nerve regeneration. This combination is chemically and pharmacologically safe and being approved for neurologicaly disorder. Citicoline which is form of vitamin B found in all cell, where as methylcobalamine vitamin B12 is the only B vitamin which is part of mineral, cobalamine contain cobalts, mineral that is known to stimulate RBC formation. Generally brain requires a consistent supply of nutrient to maintain performance efficiency, insufficiency in certain brain nutrient may lead to forgetfulness or momentary memory lapses, this can be avoided by using brain nutrients come to us from B vitamin family and form vital constituent of memory supplements. Now the importance of the combination of citicoline and methylcobalmine known to health care system to boost memory, production of brain energy, sustain cognitive function and motor skill and enhance focus and decision making thought processes. It is being sold as nutraceutical formulation by various manufacturers. This review highlights need for combination of citicoline and methylcobalamine their pharmacological and therapeutic issues and application.
Bookmark/Search this post with
FULL TEXT (PDF): 
PDF icon arastrmx_160852_2_pp_242-249.pdf
  • 3
242-249
  • English

REFERENCES

References: 

1. Ronan Jambou, Fatima El-Assaad, Valery Combes,
and Georges Emile Grau: Citicoline (CDP-choline):
What role in the treatment of complications of
infectious diseases, 1467–1470 (2009).
2. Jaouen, G., ed. Bioorganometallics: Biomolecules,
Labeling, Medicine. Weinheim: (2006).
3. Agut J, Font E, Sacristan A, Ortiz JA. Radioactivity
incorporation into different cerebral phospholipids
after oral administration of 14C methyl CDPcholine.
Arzneimittelforschung, 33:1048-
1050,(1983).
4. G-Coviella IL, Wurtman RJ. Enhancement by
cytidine of membrane phospholipid synthesis. J
Neurochem, 59:338-343 (1992).
5. D’Orlando KJ, Sandage BW Jr. Citicoline
(CDPcholine): mechanisms of action and effects in
ischemic brain injury. Neurol Res 17:281-284,
(1995).
6. Rao AM, Hatcher JF, Dempsey RJ. CDPcholine:
neuroprotection in transient forebrain ischemia of
gerbils. J Neurosci Res,58:697-705 (1999)
7. Dinsdale JR, Griffiths GK, Rowlands C, et al.
Pharmacokinetics of 14C CDP-choline.
Arzneimittelforschung, 33:1066-1070 (1983).
8. Marilyn Bachmann. B-12 Methylcobalamin - Thorne
Article - March 20, 2001.
9. Agut J, Font E, Sacrist·n A, Ortiz JA. Radioactivity
incorporation into different cerebral phospholipids
after oral administration of 14C methyl CDPcholine.
Arzneimittelforschung, 33:1048-1050
(1983).
10. G-Coviella IL, Wurtman RJ. Enhancement by
cytidine of membrane phospholipid synthesis. J
Neurochem; 59:338-343 (1992).
11. Cooper BA, Rosenblatt DS. Inherited defects of
vitamin B12 metabolism. Ann Rev Nutr, 7:291-320
(1987).
12. De la Morena E. Efficacy of CDP-choline in the
treatment of senile alterations in memory. Ann N Y
Acad Sci 640:233-236 (1991).
13. D’Orlando KJ, Sandage BW Jr. Citicoline
(CDPcholine): mechanisms of action and effects in
ischemic brain injury. Neurol Res; 17:281-284
(1995).
14. Nitta A, Itoh A, Hasegawa T, Nabeshima T.
Betaamyloid protein-induced Alzheimer’s disease
animal model. Neurosci Lett; 170:63-66 (1994).
15. Nitta A, Fukuta T, Hasegawa T, Nabeshima T.
Continuous infusion of beta-amyloid protein into
the rat cerebral ventricle induces learning
impairment and neuronal and morphological
degeneration. Jpn J Pharmacol 73:51-57 (1997).
16. Lopez I, Coviella G, Agut J, Wurtman RJ. Effect of
cytidine(5’)diphosphocholine (CDP-choline) on the
total urinary excretion of 3-methoxy-4-
hydroxyphenylglycol (MHPG) by rats and humans. J
Neural Transm; 66:129-134 (1986).
17. Voet, Judith G.; Voet, Donald .Biochemistry. New
York: J. Wiley & Sons. p. 675 (1995).
18. Banerjee, R; Ragsdale, SW "The many faces of
vitamin B12: catalysis by cobalamin-dependent
enzymes". Annual review of biochemistry 72: 209–
47 (2003).
19. Banerjee RV, Matthews RG. "Cobalamin-dependent
methionine synthase". The FASEB Journal 4 (5):
1450–9 (1990).
20. Wickramasinghe SN. "Morphology, biology and
biochemistry of cobalamin- and folate-deficient
bone marrow cells". Baillière's Clinical Haematology
8 (3): 441–59 (1995).
21. www.Google.com posted by Meher Pharma
International on innovates fixed dose combination
and approval by Government Authority.
22. .Pappu AS, Fatterpaker P, Srenivasan A. Possible
interrelationship between vitamins E and B12 in
the disturbance in methylmalonate metabolism in
vitamin E deficiency. Biochem J;172:115-121
(1978).
23. Glusker JP. Vitamin B12 and the B12 coenzymes.
Vitam Horm;50:1-76 (1995).
24. Adibhatla RM, Hatcher JF. Citicoline decreases
phospholipase A2 stimulation and hydroxyl radical
generation in transient cerebral ischemia. J
Neurosci Res;73:308-315 (2003).
25. Jayadev S, Linardic CM, Hannun YA. Identification of
arachidonic acid as a mediator of sphingomyelin
hydrolysis in response to tumor necrosis factor
alpha. J Biol Chem;269:5757-5763 (1994).
Asma et al., ARPB, 2012; Vol 2 (III) ISSN 2250-0774
(REVIEW ARTICLE)
249 | P a g e w w w . a r p b . i n f o
26. Secades JJ 1. , Frontera G. CDP-choline:
pharmacological and clinical review. Methods Find
Exp Clin Pharmacol;17:1-54 (1995).
27. Lopez I, Coviella G, Agut J, Wurtman RJ. Effect of
cytidine(5’)diphosphocholine (CDP-choline) on the
total urinary excretion of 3-methoxy-4-
hydroxyphenylglycol (MHPG) by rats and humans. J
Neural Transm;66:129-134 (1986).
28. Petkov VD, Stancheva SL, Tocuschieva L, Petkov VV.
Changes in brain biogenic monoamines induced by
the nootropic drugs adafenoxate and meclofenoxate
and by citicholine (experiments on rats). Gen
Pharmacol;21:71-75 (1990).
29. Campos EC, Schiavi C, Benedetti P, et al. Effect of
citicoline on visual acuity in amblyopia: preliminary
results. Graefes Arch Clin Exp Ophthalmol;233:307-
312 (1995).
30. Porciatti V, Schiavi C, Benedetti P, et al. Cytidine- 5’-
diphosphocholine improves visual acuity, contrast
sensitivity and visually-evoked potentials of
amblyopic subjects. Curr Eye Res;17:141-148
(1998).
31. Lozano Fernandez R. Efficacy and safety of oral
CDP-choline. Drug surveillance study in 2817 cases.
Arzneimittelforschung;33:1073-1080 (1983).
32. Grau T, Romero A, Sacristan A, Ortiz JA.
CDPcholine: acute toxicity study.
Arzneimittelforschung;33:1033-1034 (1983).
33. Romero A, Grau T, Sacristan A, Ortiz JA. Study of
subacute toxicity of CDP-choline after 30 days of
oral administration to rats.
Arzneimittelforschung;33:1035-1038 (1983).
34. Romero A, Grau T, Sacristan A, Ortiz JA.
CDPcholine: 6-month study on toxicity in dogs.
Arzneimittelforschung;33:1038-1042 (1983).
35. Fochi F, Ciampini M, Ceccarelli G. Efficacy of iron
therapy: a comparative evaluation of four iron
preparations administered to anaemic pregnant
women. J Int Med Res;13:1-11(1985).
36. Eto I, Krumdieck CL. Role of vitamin B12 and folate
deficiencies in carcinogenesis. Adv Exp Med
Biol;206:313-330 (1986).
37. Liteplo RG, Hipwell SE, Rosenblatt DS, et al.
Changes in cobalamin metabolism are associated
with the altered methionine auxotrophy of highly
growth autonomous human melanoma cells. J Cell
Physiol;149:332-338 (1991).
38. Nishizawa Y, Yamamoto T, Terada N, et al. Effects of
methylcobalamin on the proliferation of androgensensitive
or estrogen-sensitive malignant cells in
culture and in vivo. Int J Vitam Nutr Res;67:164-170
(1997).
39. Yaqub BA, Siddique A, Sulimani R. Effects of
methylcobalamin on diabetic neuropathy. Clin
Neurol Neurosurg;94:105-111 (1992).

Thank you for copying data from http://www.arastirmax.com